[{"path":"https://ahasoplakus.github.io/clinTables/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Sukalpo Saha. Maintainer, author.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Saha S (2023). clinTables: Clinical Trial Tables R. https://ahasoplakus.github.io/clinTables/, https://github.com/ahasoplakus/clinTables/.","code":"@Manual{,   title = {clinTables: Clinical Trial Tables in R},   author = {Sukalpo Saha},   year = {2023},   note = {https://ahasoplakus.github.io/clinTables/, https://github.com/ahasoplakus/clinTables/}, }"},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/CODE_OF_CONDUCT.html","id":"our-pledge","dir":"","previous_headings":"","what":"Our Pledge","title":"Contributor Covenant Code of Conduct","text":"members, contributors, leaders pledge make participation community harassment-free experience everyone, regardless age, body size, visible invisible disability, ethnicity, sex characteristics, gender identity expression, level experience, education, socio-economic status, nationality, personal appearance, race, caste, color, religion, sexual identity orientation. pledge act interact ways contribute open, welcoming, diverse, inclusive, healthy community.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/CODE_OF_CONDUCT.html","id":"our-standards","dir":"","previous_headings":"","what":"Our Standards","title":"Contributor Covenant Code of Conduct","text":"Examples behavior contributes positive environment community include: Demonstrating empathy kindness toward people respectful differing opinions, viewpoints, experiences Giving gracefully accepting constructive feedback Accepting responsibility apologizing affected mistakes, learning experience Focusing best just us individuals, overall community Examples unacceptable behavior include: use sexualized language imagery, sexual attention advances kind Trolling, insulting derogatory comments, personal political attacks Public private harassment Publishing others’ private information, physical email address, without explicit permission conduct reasonably considered inappropriate professional setting","code":""},{"path":"https://ahasoplakus.github.io/clinTables/CODE_OF_CONDUCT.html","id":"enforcement-responsibilities","dir":"","previous_headings":"","what":"Enforcement Responsibilities","title":"Contributor Covenant Code of Conduct","text":"Community leaders responsible clarifying enforcing standards acceptable behavior take appropriate fair corrective action response behavior deem inappropriate, threatening, offensive, harmful. Community leaders right responsibility remove, edit, reject comments, commits, code, wiki edits, issues, contributions aligned Code Conduct, communicate reasons moderation decisions appropriate.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/CODE_OF_CONDUCT.html","id":"scope","dir":"","previous_headings":"","what":"Scope","title":"Contributor Covenant Code of Conduct","text":"Code Conduct applies within community spaces, also applies individual officially representing community public spaces. Examples representing community include using official e-mail address, posting via official social media account, acting appointed representative online offline event.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/CODE_OF_CONDUCT.html","id":"enforcement","dir":"","previous_headings":"","what":"Enforcement","title":"Contributor Covenant Code of Conduct","text":"Instances abusive, harassing, otherwise unacceptable behavior may reported community leaders responsible enforcement codeofconduct@rstudio.com. complaints reviewed investigated promptly fairly. community leaders obligated respect privacy security reporter incident.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/CODE_OF_CONDUCT.html","id":"enforcement-guidelines","dir":"","previous_headings":"","what":"Enforcement Guidelines","title":"Contributor Covenant Code of Conduct","text":"Community leaders follow Community Impact Guidelines determining consequences action deem violation Code Conduct:","code":""},{"path":"https://ahasoplakus.github.io/clinTables/CODE_OF_CONDUCT.html","id":"1-correction","dir":"","previous_headings":"Enforcement Guidelines","what":"1. Correction","title":"Contributor Covenant Code of Conduct","text":"Community Impact: Use inappropriate language behavior deemed unprofessional unwelcome community. Consequence: private, written warning community leaders, providing clarity around nature violation explanation behavior inappropriate. public apology may requested.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/CODE_OF_CONDUCT.html","id":"2-warning","dir":"","previous_headings":"Enforcement Guidelines","what":"2. Warning","title":"Contributor Covenant Code of Conduct","text":"Community Impact: violation single incident series actions. Consequence: warning consequences continued behavior. interaction people involved, including unsolicited interaction enforcing Code Conduct, specified period time. includes avoiding interactions community spaces well external channels like social media. Violating terms may lead temporary permanent ban.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/CODE_OF_CONDUCT.html","id":"3-temporary-ban","dir":"","previous_headings":"Enforcement Guidelines","what":"3. Temporary Ban","title":"Contributor Covenant Code of Conduct","text":"Community Impact: serious violation community standards, including sustained inappropriate behavior. Consequence: temporary ban sort interaction public communication community specified period time. public private interaction people involved, including unsolicited interaction enforcing Code Conduct, allowed period. Violating terms may lead permanent ban.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/CODE_OF_CONDUCT.html","id":"4-permanent-ban","dir":"","previous_headings":"Enforcement Guidelines","what":"4. Permanent Ban","title":"Contributor Covenant Code of Conduct","text":"Community Impact: Demonstrating pattern violation community standards, including sustained inappropriate behavior, harassment individual, aggression toward disparagement classes individuals. Consequence: permanent ban sort public interaction within community.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/CODE_OF_CONDUCT.html","id":"attribution","dir":"","previous_headings":"","what":"Attribution","title":"Contributor Covenant Code of Conduct","text":"Code Conduct adapted Contributor Covenant, version 2.1, available https://www.contributor-covenant.org/version/2/1/code_of_conduct.html. Community Impact Guidelines inspired [Mozilla’s code conduct enforcement ladder][https://github.com/mozilla/inclusion]. answers common questions code conduct, see FAQ https://www.contributor-covenant.org/faq. Translations available https://www.contributor-covenant.org/translations.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/CONTRIBUTING.html","id":null,"dir":"","previous_headings":"","what":"Contributing to clinTables","title":"Contributing to clinTables","text":"outlines propose change clinTables. detailed info contributing , tidyverse packages, please see development contributing guide.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/CONTRIBUTING.html","id":"fixing-typos","dir":"","previous_headings":"","what":"Fixing typos","title":"Contributing to clinTables","text":"can fix typos, spelling mistakes, grammatical errors documentation directly using GitHub web interface, long changes made source file. generally means ’ll need edit roxygen2 comments .R, .Rd file. can find .R file generates .Rd reading comment first line.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/CONTRIBUTING.html","id":"bigger-changes","dir":"","previous_headings":"","what":"Bigger changes","title":"Contributing to clinTables","text":"want make bigger change, ’s good idea first file issue make sure someone team agrees ’s needed. ’ve found bug, please file issue illustrates bug minimal reprex (also help write unit test, needed).","code":""},{"path":"https://ahasoplakus.github.io/clinTables/CONTRIBUTING.html","id":"pull-request-process","dir":"","previous_headings":"Bigger changes","what":"Pull request process","title":"Contributing to clinTables","text":"Fork package clone onto computer. haven’t done , recommend using usethis::create_from_github(\"ahasoplakus/clinTables\", fork = TRUE). Install development dependencies devtools::install_dev_deps(), make sure package passes R CMD check running devtools::check(). R CMD check doesn’t pass cleanly, ’s good idea ask help continuing. Create Git branch pull request (PR). recommend using usethis::pr_init(\"brief-description--change\"). Make changes, commit git, create PR running usethis::pr_push(), following prompts browser. title PR briefly describe change. body PR contain Fixes #issue-number. user-facing changes, add bullet top NEWS.md (.e. just first header). Follow style described https://style.tidyverse.org/news.html.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/CONTRIBUTING.html","id":"code-style","dir":"","previous_headings":"Bigger changes","what":"Code style","title":"Contributing to clinTables","text":"New code follow tidyverse style guide. can use styler package apply styles, please don’t restyle code nothing PR. use roxygen2, Markdown syntax, documentation. use testthat unit tests. Contributions test cases included easier accept.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/CONTRIBUTING.html","id":"code-of-conduct","dir":"","previous_headings":"","what":"Code of Conduct","title":"Contributing to clinTables","text":"Please note clinTables project released Contributor Code Conduct. contributing project agree abide terms.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/index.html","id":"clintables-","dir":"","previous_headings":"","what":"Clinical Trial Tables in R","title":"Clinical Trial Tables in R","text":"clinTables shiny application visualize standard tables used Clinical Trials","code":""},{"path":"https://ahasoplakus.github.io/clinTables/index.html","id":"installation","dir":"","previous_headings":"","what":"Installation","title":"Clinical Trial Tables in R","text":"Latest dev version installation, install packages install.packages(c(\"logger\", \"haven\", \"reactable\", \"markdown\", \"shinycssloaders\", \"flextable\", \"officer\")) Run library(clinTables) access exported functions clinTables help reproducing analysis performed app. , can run application locally using:","code":"remotes::install_github(\"ahasoplakus/clinTables\") # Launch the application run_app()"},{"path":"https://ahasoplakus.github.io/clinTables/LICENSE.html","id":null,"dir":"","previous_headings":"","what":"Apache License","title":"Apache License","text":"Version 2.0, January 2004 <http://www.apache.org/licenses/>","code":""},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/LICENSE.html","id":"1-definitions","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"1. Definitions","title":"Apache License","text":"“License” shall mean terms conditions use, reproduction, distribution defined Sections 1 9 document. “Licensor” shall mean copyright owner entity authorized copyright owner granting License. “Legal Entity” shall mean union acting entity entities control, controlled , common control entity. purposes definition, “control” means () power, direct indirect, cause direction management entity, whether contract otherwise, (ii) ownership fifty percent (50%) outstanding shares, (iii) beneficial ownership entity. “” (“”) shall mean individual Legal Entity exercising permissions granted License. “Source” form shall mean preferred form making modifications, including limited software source code, documentation source, configuration files. “Object” form shall mean form resulting mechanical transformation translation Source form, including limited compiled object code, generated documentation, conversions media types. “Work” shall mean work authorship, whether Source Object form, made available License, indicated copyright notice included attached work (example provided Appendix ). “Derivative Works” shall mean work, whether Source Object form, based (derived ) Work editorial revisions, annotations, elaborations, modifications represent, whole, original work authorship. purposes License, Derivative Works shall include works remain separable , merely link (bind name) interfaces , Work Derivative Works thereof. “Contribution” shall mean work authorship, including original version Work modifications additions Work Derivative Works thereof, intentionally submitted Licensor inclusion Work copyright owner individual Legal Entity authorized submit behalf copyright owner. purposes definition, “submitted” means form electronic, verbal, written communication sent Licensor representatives, including limited communication electronic mailing lists, source code control systems, issue tracking systems managed , behalf , Licensor purpose discussing improving Work, excluding communication conspicuously marked otherwise designated writing copyright owner “Contribution.” “Contributor” shall mean Licensor individual Legal Entity behalf Contribution received Licensor subsequently incorporated within Work.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/LICENSE.html","id":"2-grant-of-copyright-license","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"2. Grant of Copyright License","title":"Apache License","text":"Subject terms conditions License, Contributor hereby grants perpetual, worldwide, non-exclusive, -charge, royalty-free, irrevocable copyright license reproduce, prepare Derivative Works , publicly display, publicly perform, sublicense, distribute Work Derivative Works Source Object form.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/LICENSE.html","id":"3-grant-of-patent-license","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"3. Grant of Patent License","title":"Apache License","text":"Subject terms conditions License, Contributor hereby grants perpetual, worldwide, non-exclusive, -charge, royalty-free, irrevocable (except stated section) patent license make, made, use, offer sell, sell, import, otherwise transfer Work, license applies patent claims licensable Contributor necessarily infringed Contribution(s) alone combination Contribution(s) Work Contribution(s) submitted. institute patent litigation entity (including cross-claim counterclaim lawsuit) alleging Work Contribution incorporated within Work constitutes direct contributory patent infringement, patent licenses granted License Work shall terminate date litigation filed.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/LICENSE.html","id":"4-redistribution","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"4. Redistribution","title":"Apache License","text":"may reproduce distribute copies Work Derivative Works thereof medium, without modifications, Source Object form, provided meet following conditions: () must give recipients Work Derivative Works copy License; (b) must cause modified files carry prominent notices stating changed files; (c) must retain, Source form Derivative Works distribute, copyright, patent, trademark, attribution notices Source form Work, excluding notices pertain part Derivative Works; (d) Work includes “NOTICE” text file part distribution, Derivative Works distribute must include readable copy attribution notices contained within NOTICE file, excluding notices pertain part Derivative Works, least one following places: within NOTICE text file distributed part Derivative Works; within Source form documentation, provided along Derivative Works; , within display generated Derivative Works, wherever third-party notices normally appear. contents NOTICE file informational purposes modify License. may add attribution notices within Derivative Works distribute, alongside addendum NOTICE text Work, provided additional attribution notices construed modifying License. may add copyright statement modifications may provide additional different license terms conditions use, reproduction, distribution modifications, Derivative Works whole, provided use, reproduction, distribution Work otherwise complies conditions stated License.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/LICENSE.html","id":"5-submission-of-contributions","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"5. Submission of Contributions","title":"Apache License","text":"Unless explicitly state otherwise, Contribution intentionally submitted inclusion Work Licensor shall terms conditions License, without additional terms conditions. Notwithstanding , nothing herein shall supersede modify terms separate license agreement may executed Licensor regarding Contributions.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/LICENSE.html","id":"6-trademarks","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"6. Trademarks","title":"Apache License","text":"License grant permission use trade names, trademarks, service marks, product names Licensor, except required reasonable customary use describing origin Work reproducing content NOTICE file.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/LICENSE.html","id":"7-disclaimer-of-warranty","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"7. Disclaimer of Warranty","title":"Apache License","text":"Unless required applicable law agreed writing, Licensor provides Work (Contributor provides Contributions) “” BASIS, WITHOUT WARRANTIES CONDITIONS KIND, either express implied, including, without limitation, warranties conditions TITLE, NON-INFRINGEMENT, MERCHANTABILITY, FITNESS PARTICULAR PURPOSE. solely responsible determining appropriateness using redistributing Work assume risks associated exercise permissions License.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/LICENSE.html","id":"8-limitation-of-liability","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"8. Limitation of Liability","title":"Apache License","text":"event legal theory, whether tort (including negligence), contract, otherwise, unless required applicable law (deliberate grossly negligent acts) agreed writing, shall Contributor liable damages, including direct, indirect, special, incidental, consequential damages character arising result License use inability use Work (including limited damages loss goodwill, work stoppage, computer failure malfunction, commercial damages losses), even Contributor advised possibility damages.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/LICENSE.html","id":"9-accepting-warranty-or-additional-liability","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"9. Accepting Warranty or Additional Liability","title":"Apache License","text":"redistributing Work Derivative Works thereof, may choose offer, charge fee , acceptance support, warranty, indemnity, liability obligations /rights consistent License. However, accepting obligations, may act behalf sole responsibility, behalf Contributor, agree indemnify, defend, hold Contributor harmless liability incurred , claims asserted , Contributor reason accepting warranty additional liability. END TERMS CONDITIONS","code":""},{"path":"https://ahasoplakus.github.io/clinTables/LICENSE.html","id":"appendix-how-to-apply-the-apache-license-to-your-work","dir":"","previous_headings":"","what":"APPENDIX: How to apply the Apache License to your work","title":"Apache License","text":"apply Apache License work, attach following boilerplate notice, fields enclosed brackets [] replaced identifying information. (Don’t include brackets!) text enclosed appropriate comment syntax file format. also recommend file class name description purpose included “printed page” copyright notice easier identification within third-party archives.","code":"Copyright [yyyy] [name of copyright owner]  Licensed under the Apache License, Version 2.0 (the \"License\"); you may not use this file except in compliance with the License. You may obtain a copy of the License at    http://www.apache.org/licenses/LICENSE-2.0  Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an \"AS IS\" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License."},{"path":"https://ahasoplakus.github.io/clinTables/reference/adae.html","id":null,"dir":"Reference","previous_headings":"","what":"Adverse Events Dataset. — adae","title":"Adverse Events Dataset. — adae","text":"Adverse Events Dataset.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/adae.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Adverse Events Dataset. — adae","text":"","code":"data(adae)"},{"path":"https://ahasoplakus.github.io/clinTables/reference/adae.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Adverse Events Dataset. — adae","text":"Data frame 1934 features 92 fields","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/adae.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Adverse Events Dataset. — adae","text":"https://github.com/insightsengineering/random.cdisc.data/tree/main/data","code":""},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/adae_by_sev_tox.html","id":null,"dir":"Reference","previous_headings":"","what":"Adverse Events Table by Body System and Severity/Toxicity — adae_by_sev_tox","title":"Adverse Events Table by Body System and Severity/Toxicity — adae_by_sev_tox","text":"Adverse Events Table Body System Severity/Toxicity","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/adae_by_sev_tox.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Adverse Events Table by Body System and Severity/Toxicity — adae_by_sev_tox","text":"","code":"adae_by_sev_tox(   adsl,   df_adae,   colsby = \"ARM\",   grade_val = \"AESEV\",   class_val = \"AESOC\",   term_val = \"AEDECOD\",   default_view = TRUE )"},{"path":"https://ahasoplakus.github.io/clinTables/reference/adae_by_sev_tox.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Adverse Events Table by Body System and Severity/Toxicity — adae_by_sev_tox","text":"adsl Input ADSL data df_adae Input ADAE data colsby Column Variable (default: ARM) grade_val AE Severity AE Toxicity Grade .e. AESEV AETOXGR class_val Sytem Organ Class/Body System Class .e. AESOC AEBODSYS term_val Dictionary Derived Term .e. AEDECOD AETERM default_view Logical TRUE FALSE","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/adae_by_sev_tox.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Adverse Events Table by Body System and Severity/Toxicity — adae_by_sev_tox","text":"rtable object","code":""},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/adae_by_sev_tox.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Adverse Events Table by Body System and Severity/Toxicity — adae_by_sev_tox","text":"","code":"adsl <- random.cdisc.data::cadsl adae <- random.cdisc.data::cadae  ae_by_sev_tox_table <- adae_by_sev_tox(   adsl = adsl,   df_adae = adae,   colsby = \"ARM\",   grade_val = \"AESEV\",   class_val = \"AESOC\",   term_val = \"AEDECOD\",   default_view = TRUE )  ae_by_sev_tox_table #> Primary System Organ Class                         A: Drug X (N = 134)                                 B: Placebo (N = 134)                              C: Combination (N = 132)       #>     Dictionary-Derived Term       N           MILD       MODERATE      SEVERE         N           MILD       MODERATE      SEVERE         N           MILD       MODERATE      SEVERE   #> --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- #> cl A                                                                                                                                                                                    #>   dcd A.1.1.1.1               50 (37.3%)   50 (37.3%)       0            0        45 (33.6%)   45 (33.6%)       0            0        63 (47.7%)   63 (47.7%)       0            0      #>   dcd A.1.1.1.2               48 (35.8%)       0        48 (35.8%)       0        48 (35.8%)       0        48 (35.8%)       0        50 (37.9%)       0        50 (37.9%)       0      #> cl B                                                                                                                                                                                    #>   dcd B.1.1.1.1               47 (35.1%)       0            0        47 (35.1%)   49 (36.6%)       0            0        49 (36.6%)   43 (32.6%)       0            0        43 (32.6%) #>   dcd B.2.1.2.1               49 (36.6%)       0        49 (36.6%)       0        44 (32.8%)       0        44 (32.8%)       0        52 (39.4%)       0        52 (39.4%)       0      #>   dcd B.2.2.3.1               48 (35.8%)   48 (35.8%)       0            0        54 (40.3%)   54 (40.3%)       0            0        51 (38.6%)   51 (38.6%)       0            0      #> cl C                                                                                                                                                                                    #>   dcd C.1.1.1.3               43 (32.1%)       0            0        43 (32.1%)   46 (34.3%)       0            0        46 (34.3%)   43 (32.6%)       0            0        43 (32.6%) #>   dcd C.2.1.2.1               35 (26.1%)       0        35 (26.1%)       0        48 (35.8%)       0        48 (35.8%)       0        55 (41.7%)       0        55 (41.7%)       0      #> cl D                                                                                                                                                                                    #>   dcd D.1.1.1.1               50 (37.3%)       0            0        50 (37.3%)   42 (31.3%)       0            0        42 (31.3%)   51 (38.6%)       0            0        51 (38.6%) #>   dcd D.1.1.4.2               48 (35.8%)       0        48 (35.8%)       0        42 (31.3%)       0        42 (31.3%)       0        50 (37.9%)       0        50 (37.9%)       0      #>   dcd D.2.1.5.3               47 (35.1%)   47 (35.1%)       0            0        58 (43.3%)   58 (43.3%)       0            0        57 (43.2%)   57 (43.2%)       0            0"},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/add_adae_flags.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Add Flags to ADAE — add_adae_flags","text":"","code":"add_adae_flags(df)"},{"path":"https://ahasoplakus.github.io/clinTables/reference/add_adae_flags.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Add Flags to ADAE — add_adae_flags","text":"df (data.frame) ADAE dataset.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/add_adae_flags.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Add Flags to ADAE — add_adae_flags","text":"ADAE dataset added flags","code":""},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/add_adae_flags.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Add Flags to ADAE — add_adae_flags","text":"","code":"library(clinTables) library(dplyr) #>  #> Attaching package: 'dplyr' #> The following objects are masked from 'package:stats': #>  #>     filter, lag #> The following objects are masked from 'package:base': #>  #>     intersect, setdiff, setequal, union data(adsl) data(adae) adae_ <- add_adae_flags(adae)  tbl <- select(adae_, c(\"USUBJID\", setdiff(names(adae_), names(adae)))) slice_head(tbl, n = 5) #> # A tibble: 5 x 16 #>   USUBJID     SER   SAEFATAL SAELIFE SAEHOSP SAEDISAB SAECONG SAEMIE WD    WDSM  #>   <chr>       <lgl> <lgl>    <lgl>   <lgl>   <lgl>    <lgl>   <lgl>  <lgl> <lgl> #> 1 AB12345-BR~ FALSE FALSE    FALSE   FALSE   FALSE    FALSE   FALSE  FALSE FALSE #> 2 AB12345-BR~ FALSE FALSE    FALSE   FALSE   FALSE    FALSE   FALSE  FALSE FALSE #> 3 AB12345-BR~ TRUE  FALSE    FALSE   FALSE   TRUE     FALSE   FALSE  FALSE FALSE #> 4 AB12345-BR~ TRUE  FALSE    FALSE   FALSE   FALSE    TRUE    FALSE  TRUE  FALSE #> 5 AB12345-BR~ FALSE FALSE    FALSE   FALSE   FALSE    FALSE   FALSE  FALSE TRUE  #> # i 6 more variables: AEINT <lgl>, AERED <lgl>, AED <lgl>, AEMIE <lgl>, #> #   CTC35 <lgl>, CTC45 <lgl>"},{"path":"https://ahasoplakus.github.io/clinTables/reference/adlb.html","id":null,"dir":"Reference","previous_headings":"","what":"Laboratory Analysis Dataset. — adlb","title":"Laboratory Analysis Dataset. — adlb","text":"Laboratory Analysis Dataset.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/adlb.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Laboratory Analysis Dataset. — adlb","text":"","code":"data(adlb)"},{"path":"https://ahasoplakus.github.io/clinTables/reference/adlb.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Laboratory Analysis Dataset. — adlb","text":"Data frame 8400 features 102 fields","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/adlb.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Laboratory Analysis Dataset. — adlb","text":"https://github.com/insightsengineering/random.cdisc.data/tree/main/data","code":""},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/adsl.html","id":null,"dir":"Reference","previous_headings":"","what":"Subject Level Analysis Dataset. — adsl","title":"Subject Level Analysis Dataset. — adsl","text":"Subject Level Analysis Dataset.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/adsl.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Subject Level Analysis Dataset. — adsl","text":"","code":"data(adsl)"},{"path":"https://ahasoplakus.github.io/clinTables/reference/adsl.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Subject Level Analysis Dataset. — adsl","text":"Data frame 400 features 55 fields","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/adsl.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Subject Level Analysis Dataset. — adsl","text":"https://github.com/insightsengineering/random.cdisc.data/tree/main/data","code":""},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/advs.html","id":null,"dir":"Reference","previous_headings":"","what":"Vital Signs Dataset. — advs","title":"Vital Signs Dataset. — advs","text":"Vital Signs Dataset.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/advs.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Vital Signs Dataset. — advs","text":"","code":"data(advs)"},{"path":"https://ahasoplakus.github.io/clinTables/reference/advs.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Vital Signs Dataset. — advs","text":"Data frame 16800 features 87 fields","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/advs.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Vital Signs Dataset. — advs","text":"https://github.com/insightsengineering/random.cdisc.data/tree/main/data","code":""},{"path":[]},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_adae_by_sev_tox.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Adverse Events Table by Body System and Severity/Toxicity — build_adae_by_sev_tox","text":"","code":"build_adae_by_sev_tox(   adsl,   df_adae,   colsby = \"ARM\",   filter_cond = NULL,   grade_val = \"AESEV\",   class_val = \"AESOC\",   term_val = \"AEDECOD\",   default_view = TRUE )"},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_adae_by_sev_tox.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Adverse Events Table by Body System and Severity/Toxicity — build_adae_by_sev_tox","text":"adsl (data.frame) ADSL dataset. df_adae (data.frame) ADAE dataset. colsby (character) Variable used split table columns. filter_cond (character) Filtering condition required df_adae. grade_val (character) AE Severity AE Toxicity Grade .e. AESEV AETOXGR class_val (character) System Organ Class/Body System Class .e. AESOC AEBODSYS term_val (character) Dictionary Derived Term .e. AEDECOD AETERM default_view (logical)TRUE displays values grade_val columns.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_adae_by_sev_tox.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Adverse Events Table by Body System and Severity/Toxicity — build_adae_by_sev_tox","text":"rtable object","code":""},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_adae_by_sev_tox.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Adverse Events Table by Body System and Severity/Toxicity — build_adae_by_sev_tox","text":"Primary System Organ Class  : Drug X (N = 134)  B: Placebo (N = 134)  C: Combination (N = 132)  Patients (N = 400) Dictionary-Derived Term n MILD MODERATE SEVERE n MILD MODERATE SEVERE n MILD MODERATE SEVERE n MILD MODERATE SEVERE cl                 dcd .1.1.1.1 50 (37.3%) 50 (37.3%) 0 0 45 (33.6%) 45 (33.6%) 0 0 63 (47.7%) 63 (47.7%) 0 0 158 (39.5%) 158 (39.5%) 0 0 dcd .1.1.1.2 48 (35.8%) 0 48 (35.8%) 0 48 (35.8%) 0 48 (35.8%) 0 50 (37.9%) 0 50 (37.9%) 0 146 (36.5%) 0 146 (36.5%) 0 cl B                 dcd B.1.1.1.1 47 (35.1%) 0 0 47 (35.1%) 49 (36.6%) 0 0 49 (36.6%) 43 (32.6%) 0 0 43 (32.6%) 139 (34.8%) 0 0 139 (34.8%) dcd B.2.1.2.1 49 (36.6%) 0 49 (36.6%) 0 44 (32.8%) 0 44 (32.8%) 0 52 (39.4%) 0 52 (39.4%) 0 145 (36.2%) 0 145 (36.2%) 0 dcd B.2.2.3.1 48 (35.8%) 48 (35.8%) 0 0 54 (40.3%) 54 (40.3%) 0 0 51 (38.6%) 51 (38.6%) 0 0 153 (38.2%) 153 (38.2%) 0 0 cl C                 dcd C.1.1.1.3 43 (32.1%) 0 0 43 (32.1%) 46 (34.3%) 0 0 46 (34.3%) 43 (32.6%) 0 0 43 (32.6%) 132 (33.0%) 0 0 132 (33.0%) dcd C.2.1.2.1 35 (26.1%) 0 35 (26.1%) 0 48 (35.8%) 0 48 (35.8%) 0 55 (41.7%) 0 55 (41.7%) 0 138 (34.5%) 0 138 (34.5%) 0 cl D                 dcd D.1.1.1.1 50 (37.3%) 0 0 50 (37.3%) 42 (31.3%) 0 0 42 (31.3%) 51 (38.6%) 0 0 51 (38.6%) 143 (35.8%) 0 0 143 (35.8%) dcd D.1.1.4.2 48 (35.8%) 0 48 (35.8%) 0 42 (31.3%) 0 42 (31.3%) 0 50 (37.9%) 0 50 (37.9%) 0 140 (35.0%) 0 140 (35.0%) 0 dcd D.2.1.5.3 47 (35.1%) 47 (35.1%) 0 0 58 (43.3%) 58 (43.3%) 0 0 57 (43.2%) 57 (43.2%) 0 0 162 (40.5%) 162 (40.5%) 0 0","code":"library(clinTables) library(rtables) #> Loading required package: formatters #> Loading required package: magrittr #> Warning: package 'magrittr' was built under R version 4.1.3 data(adsl) data(adae)  tbl <- build_adae_by_sev_tox(   adsl = adsl,   df_adae = adae,   colsby = \"ARM\",   grade_val = \"AESEV\",   class_val = \"AESOC\",   term_val = \"AEDECOD\",   default_view = TRUE )  # \\dontrun{ tt_to_flextable(tbl) #> Loading required namespace: flextable .cl-8d1ee5e8{table-layout:auto;}.cl-8d154178{font-family:'Arial';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-8d154179{font-family:'courier';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-8d18c582{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-8d18c583{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-8d18c584{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:0;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-8d18c585{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:10pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-8d18ec38{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8d18ec39{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8d18ec3a{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8d18ec3b{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8d18ec3c{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8d18ec3d{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8d18ec3e{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8d18ec3f{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8d18ec40{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8d18ec41{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8d18ec42{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8d19137a{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8d19137b{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8d19137c{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8d19137d{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}Primary System Organ ClassA: Drug X (N = 134)B: Placebo (N = 134)C: Combination (N = 132)All Patients (N = 400)    Dictionary-Derived TermnMILDMODERATESEVEREnMILDMODERATESEVEREnMILDMODERATESEVEREnMILDMODERATESEVEREcl A  dcd A.1.1.1.150 (37.3%)50 (37.3%)0045 (33.6%)45 (33.6%)0063 (47.7%)63 (47.7%)00158 (39.5%)158 (39.5%)00  dcd A.1.1.1.248 (35.8%)048 (35.8%)048 (35.8%)048 (35.8%)050 (37.9%)050 (37.9%)0146 (36.5%)0146 (36.5%)0cl B  dcd B.1.1.1.147 (35.1%)0047 (35.1%)49 (36.6%)0049 (36.6%)43 (32.6%)0043 (32.6%)139 (34.8%)00139 (34.8%)  dcd B.2.1.2.149 (36.6%)049 (36.6%)044 (32.8%)044 (32.8%)052 (39.4%)052 (39.4%)0145 (36.2%)0145 (36.2%)0  dcd B.2.2.3.148 (35.8%)48 (35.8%)0054 (40.3%)54 (40.3%)0051 (38.6%)51 (38.6%)00153 (38.2%)153 (38.2%)00cl C  dcd C.1.1.1.343 (32.1%)0043 (32.1%)46 (34.3%)0046 (34.3%)43 (32.6%)0043 (32.6%)132 (33.0%)00132 (33.0%)  dcd C.2.1.2.135 (26.1%)035 (26.1%)048 (35.8%)048 (35.8%)055 (41.7%)055 (41.7%)0138 (34.5%)0138 (34.5%)0cl D  dcd D.1.1.1.150 (37.3%)0050 (37.3%)42 (31.3%)0042 (31.3%)51 (38.6%)0051 (38.6%)143 (35.8%)00143 (35.8%)  dcd D.1.1.4.248 (35.8%)048 (35.8%)042 (31.3%)042 (31.3%)050 (37.9%)050 (37.9%)0140 (35.0%)0140 (35.0%)0  dcd D.2.1.5.347 (35.1%)47 (35.1%)0058 (43.3%)58 (43.3%)0057 (43.2%)57 (43.2%)00162 (40.5%)162 (40.5%)00# }"},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_adae_summary.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Create ADAE Summary Table — build_adae_summary","text":"","code":"build_adae_summary(adae, filter_cond = NULL, event_vars, trt_var)"},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_adae_summary.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Create ADAE Summary Table — build_adae_summary","text":"adae (data.frame) ADAE dataset. filter_cond (character) Filtering condition required adae. event_vars (vector character) Variables added source ADAE add_adae_flags(). trt_var (character) Arm variable used split table columns.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_adae_summary.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Create ADAE Summary Table — build_adae_summary","text":"List containing layout object ADAE Summary Table filtered ADAE data","code":""},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_adae_summary.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Create ADAE Summary Table — build_adae_summary","text":": Drug X B: Placebo C: Combination Patients Adverse Events (N=134) (N=134) (N=132) (N=400) Serious AE 104 (77.6%) 101 (75.4%) 99 (75.0%) 304 (76.0%) SAEs fatal outcome 76 (56.7%) 70 (52.2%) 75 (56.8%) 221 (55.2%) Life-threatening SAEs 9 (6.7%) 13 (9.7%) 19 (14.4%) 41 (10.2%) SAEs requiring hospitalization 24 (17.9%) 28 (20.9%) 30 (22.7%) 82 (20.5%) SAEs resulting substantial disruption normal life functions 28 (20.9%) 21 (15.7%) 23 (17.4%) 72 (18.0%) Congenital anomaly birth defect 26 (19.4%) 27 (20.1%) 20 (15.2%) 73 (18.2%) SAEs 30 (22.4%) 37 (27.6%) 32 (24.2%) 99 (24.8%) AE leading permanent discontinuation study drug 27 (20.1%) 26 (19.4%) 30 (22.7%) 83 (20.8%) AE leading dose modification/interruption 66 (49.3%) 76 (56.7%) 74 (56.1%) 216 (54.0%) AE leading interruption study drug 4 (3.0%) 4 (3.0%) 3 (2.3%) 11 (2.8%) AE leading reduction study drug 46 (34.3%) 46 (34.3%) 51 (38.6%) 143 (35.8%) AE leading dose delay study drug 20 (14.9%) 28 (20.9%) 30 (22.7%) 78 (19.5%) AEs 34 (25.4%) 48 (35.8%) 46 (34.8%) 128 (32.0%) AE 122 (91.0%) 123 (91.8%) 120 (90.9%) 365 (91.2%) MILD 7 (5.2%) 9 (6.7%) 4 (3.0%) 20 (5.0%) MODERATE 24 (17.9%) 24 (17.9%) 23 (17.4%) 71 (17.8%) SEVERE 91 (67.9%) 90 (67.2%) 93 (70.5%) 274 (68.5%) Grade 3-5 AE 109 (81.3%) 104 (77.6%) 109 (82.6%) 322 (80.5%) Grade 4/5 AE 91 (67.9%) 90 (67.2%) 93 (70.5%) 274 (68.5%)","code":"library(clinTables) library(rtables) data(adsl) data(adae) adae_ <- add_adae_flags(adae) lyt <- build_adae_summary(   adae = adae_,   filter_cond = NULL,   event_vars = setdiff(names(adae_), names(adae)),   trt_var = \"ARM\" ) tbl <- build_table(lyt = lyt$lyt, df = lyt$df_out, alt_counts_df = adsl)  # \\dontrun{ tt_to_flextable(tbl) .cl-8f38628c{table-layout:auto;}.cl-8f2ffa20{font-family:'Arial';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-8f2ffa21{font-family:'courier';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-8f330cba{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-8f330cbb{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-8f330cbc{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:10pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-8f330cbd{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:20pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-8f330cbe{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8f330cbf{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8f330cc0{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8f330cc1{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8f330cc2{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8f330cc3{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8f330cc4{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8f333816{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8f333817{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8f333818{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8f333819{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8f33381a{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}A: Drug XB: PlaceboC: CombinationAll PatientsAdverse Events(N=134)(N=134)(N=132)(N=400)  Serious AE104 (77.6%)101 (75.4%)99 (75.0%)304 (76.0%)    SAEs with fatal outcome76 (56.7%)70 (52.2%)75 (56.8%)221 (55.2%)    Life-threatening SAEs9 (6.7%)13 (9.7%)19 (14.4%)41 (10.2%)    SAEs requiring hospitalization24 (17.9%)28 (20.9%)30 (22.7%)82 (20.5%)    SAEs resulting in substantial disruption of normal life functions28 (20.9%)21 (15.7%)23 (17.4%)72 (18.0%)    Congenital anomaly or birth defect26 (19.4%)27 (20.1%)20 (15.2%)73 (18.2%)    Other SAEs30 (22.4%)37 (27.6%)32 (24.2%)99 (24.8%)  AE leading to permanent discontinuation of study drug27 (20.1%)26 (19.4%)30 (22.7%)83 (20.8%)  AE leading to dose modification/interruption66 (49.3%)76 (56.7%)74 (56.1%)216 (54.0%)    AE leading to interruption of study drug4 (3.0%)4 (3.0%)3 (2.3%)11 (2.8%)    AE leading to reduction of study drug46 (34.3%)46 (34.3%)51 (38.6%)143 (35.8%)    AE leading to dose delay of study drug20 (14.9%)28 (20.9%)30 (22.7%)78 (19.5%)    Other AEs34 (25.4%)48 (35.8%)46 (34.8%)128 (32.0%)  Any AE122 (91.0%)123 (91.8%)120 (90.9%)365 (91.2%)    MILD7 (5.2%)9 (6.7%)4 (3.0%)20 (5.0%)    MODERATE24 (17.9%)24 (17.9%)23 (17.4%)71 (17.8%)    SEVERE91 (67.9%)90 (67.2%)93 (70.5%)274 (68.5%)    Grade 3-5 AE109 (81.3%)104 (77.6%)109 (82.6%)322 (80.5%)    Grade 4/5 AE91 (67.9%)90 (67.2%)93 (70.5%)274 (68.5%)# }"},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_adsl.html","id":null,"dir":"Reference","previous_headings":"","what":"Build adsl dataset — build_adsl","title":"Build adsl dataset — build_adsl","text":"function build demographic table full set","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_adsl.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Build adsl dataset — build_adsl","text":"","code":"build_adsl(   title = \"x.x: Study Subject Data\",   subtitle = c(\"x.x.x: Demographic Characteristics\",     \"Table x.x.x.x: Demographic Characteristics - Full Analysis Set\"),   footer = \"Source: ADSL DDMMYYYY hh:mm; Listing x.xx; SDTM package: DDMMYYYY\",   split_cols_by = \"ARM\",   summ_vars = c(\"AGE\", \"SEX\", \"COUNTRY\") )"},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_adsl.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Build adsl dataset — build_adsl","text":"title (character) Title demographic table. subtitle (character) Subtitle demographic table. footer (character) Footer demographic table. split_cols_by (character) Arm variable used split table columns. summ_vars (character) Variables df include table.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_adsl.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Build adsl dataset — build_adsl","text":"tabletree object.","code":""},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_adsl.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Build adsl dataset — build_adsl","text":"","code":"lyt <- build_adsl(   split_cols_by = \"ARM\",   summ_vars = c(\"AGE\", \"RACE\") )   ## Use the tabletree object to within build_table rtables::build_table(lyt, random.cdisc.data::cadsl) #> x.x: Study Subject Data #> x.x.x: Demographic Characteristics #> Table x.x.x.x: Demographic Characteristics - Full Analysis Set #>  #> ------------------------------------------------------------------------------------------------------- #>                                                A: Drug X    B: Placebo    C: Combination   All Patients #> Characteristic                                  (N=134)       (N=134)        (N=132)         (N=400)    #> ------------------------------------------------------------------------------------------------------- #> AGE                                                                                                     #>   n                                               134           134            132             400      #>   Mean, SD                                    33.8 (6.6)    35.4 (7.9)      35.4 (7.7)      34.9 (7.4)  #>   Standard Error                                  0.6           0.7            0.7             0.4      #>   Median                                         33.0          35.0            35.0            34.0     #>   Min-Max                                     21.0 - 50.0   21.0 - 62.0    20.0 - 69.0     20.0 - 69.0  #>   IQR                                         28.0 - 39.0   30.0 - 40.0    30.0 - 40.0     29.0 - 39.0  #> RACE                                                                                                    #>   n                                               134           134            132             400      #>   ASIAN                                       68 (50.7%)     67 (50%)       73 (55.3%)      208 (52%)   #>   BLACK OR AFRICAN AMERICAN                   31 (23.1%)    28 (20.9%)      32 (24.2%)      91 (22.8%)  #>   WHITE                                       27 (20.1%)    26 (19.4%)      21 (15.9%)      74 (18.5%)  #>   AMERICAN INDIAN OR ALASKA NATIVE              8 (6%)       11 (8.2%)       6 (4.5%)       25 (6.2%)   #>   MULTIPLE                                         0         1 (0.7%)           0            1 (0.2%)   #>   NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER        0         1 (0.7%)           0            1 (0.2%)   #>   OTHER                                            0             0              0               0       #>   UNKNOWN                                          0             0              0               0       #> ------------------------------------------------------------------------------------------------------- #>  #> Source: ADSL DDMMYYYY hh:mm; Listing x.xx; SDTM package: DDMMYYYY"},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_adsl_chars_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Baseline Demographic and Clinical Characteristics — build_adsl_chars_table","text":"","code":"build_adsl_chars_table(   title = \"x.x: Study Subject Data\",   subtitle = c(\"x.x.x: Demographic Characteristics\",     \"Table x.x.x.x: Demographic Characteristics - Full Analysis Set\"),   footer = \"Source: ADSL DDMMYYYY hh:mm; Listing x.xx; SDTM package: DDMMYYYY\",   split_cols_by = \"ARM\",   summ_vars = c(\"AGE\", \"SEX\", \"COUNTRY\"),   disp_stat = c(\"n\", \"mean_sd\", \"se\", \"median\", \"range\", \"quantiles\", \"count_fraction\") )"},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_adsl_chars_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Baseline Demographic and Clinical Characteristics — build_adsl_chars_table","text":"title (character) Title demographic table. subtitle (character) Subtitle demographic table. footer (character) Footer demographic table. split_cols_by (character) Arm variable used split table columns. summ_vars (vector character) Variables df include table. disp_stat (vector character) Statistics display.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_adsl_chars_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Baseline Demographic and Clinical Characteristics — build_adsl_chars_table","text":"tabletree object.","code":""},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_adsl_chars_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Baseline Demographic and Clinical Characteristics — build_adsl_chars_table","text":"Table x.x.x.x: Demographic Characteristics - Full Analysis Set x.x.x: Demographic Characteristics x.x: Study Subject Data  : Drug X B: Placebo C: Combination Patients Baseline Characteristic (N=134) (N=134) (N=132) (N=400) AGE     n 134 134 132 400 Mean, SD 33.8 (6.6) 35.4 (7.9) 35.4 (7.7) 34.9 (7.4) Standard Error 0.6 0.7 0.7 0.4 Median 33.0 35.0 35.0 34.0 Min-Max 21.0 - 50.0 21.0 - 62.0 20.0 - 69.0 20.0 - 69.0 IQR 28.0 - 39.0 30.0 - 40.0 30.0 - 40.0 29.0 - 39.0 RACE     n 134 134 132 400 ASIAN 68 (50.7%) 67 (50%) 73 (55.3%) 208 (52%) BLACK AFRICAN AMERICAN 31 (23.1%) 28 (20.9%) 32 (24.2%) 91 (22.8%) WHITE 27 (20.1%) 26 (19.4%) 21 (15.9%) 74 (18.5%) AMERICAN INDIAN ALASKA NATIVE 8 (6%) 11 (8.2%) 6 (4.5%) 25 (6.2%) MULTIPLE 0 1 (0.7%) 0 1 (0.2%) NATIVE HAWAIIAN PACIFIC ISLANDER 0 1 (0.7%) 0 1 (0.2%) 0 0 0 0 UNKNOWN 0 0 0 0 Source: ADSL DDMMYYYY hh:mm; Listing x.xx; SDTM package: DDMMYYYY","code":"library(clinTables) data(adsl) lyt <- build_adsl_chars_table(   split_cols_by = \"ARM\",   summ_vars = c(\"AGE\", \"RACE\") ) tbl <- rtables::build_table(lyt, adsl)  # \\dontrun{ tt_to_flextable(tbl) .cl-8fee9e26{table-layout:auto;}.cl-8fe68632{font-family:'Arial';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-8fe68633{font-family:'courier';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-8fe9845e{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-8fe9845f{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-8fe98460{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:0;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-8fe98461{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:10pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-8fe9ab8c{background-color:transparent;vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9ab8d{background-color:transparent;vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9ab8e{background-color:transparent;vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9ab8f{background-color:transparent;vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9ab90{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9ab91{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9ab92{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9ab93{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9ab94{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9ab95{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9ab96{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9d260{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9d261{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9d262{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9d263{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9d264{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9d265{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9d266{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9d267{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9d268{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9d269{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9d26a{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9f95c{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9f95d{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9f95e{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9f95f{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9f960{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9f961{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9f962{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9f963{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9f964{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9f965{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fe9f966{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fea2076{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fea2077{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fea2078{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fea2079{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(255, 255, 255, 0.00);border-top: 0 solid rgba(255, 255, 255, 0.00);border-left: 0 solid rgba(255, 255, 255, 0.00);border-right: 0 solid rgba(255, 255, 255, 0.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fea207a{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(255, 255, 255, 0.00);border-top: 0 solid rgba(255, 255, 255, 0.00);border-left: 0 solid rgba(255, 255, 255, 0.00);border-right: 0 solid rgba(255, 255, 255, 0.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fea207b{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(255, 255, 255, 0.00);border-top: 0 solid rgba(255, 255, 255, 0.00);border-left: 0 solid rgba(255, 255, 255, 0.00);border-right: 0 solid rgba(255, 255, 255, 0.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-8fea207c{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(255, 255, 255, 0.00);border-top: 0 solid rgba(255, 255, 255, 0.00);border-left: 0 solid rgba(255, 255, 255, 0.00);border-right: 0 solid rgba(255, 255, 255, 0.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}Table x.x.x.x: Demographic Characteristics - Full Analysis Setx.x.x: Demographic Characteristicsx.x: Study Subject DataA: Drug XB: PlaceboC: CombinationAll PatientsBaseline Characteristic(N=134)(N=134)(N=132)(N=400)AGE  n134134132400  Mean, SD33.8 (6.6)35.4 (7.9)35.4 (7.7)34.9 (7.4)  Standard Error0.60.70.70.4  Median33.035.035.034.0  Min-Max21.0 - 50.021.0 - 62.020.0 - 69.020.0 - 69.0  IQR28.0 - 39.030.0 - 40.030.0 - 40.029.0 - 39.0RACE  n134134132400  ASIAN68 (50.7%)67 (50%)73 (55.3%)208 (52%)  BLACK OR AFRICAN AMERICAN31 (23.1%)28 (20.9%)32 (24.2%)91 (22.8%)  WHITE27 (20.1%)26 (19.4%)21 (15.9%)74 (18.5%)  AMERICAN INDIAN OR ALASKA NATIVE8 (6%)11 (8.2%)6 (4.5%)25 (6.2%)  MULTIPLE01 (0.7%)01 (0.2%)  NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER01 (0.7%)01 (0.2%)  OTHER0000  UNKNOWN0000Source: ADSL DDMMYYYY hh:mm; Listing x.xx; SDTM package: DDMMYYYY# }"},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_demog_characteristics_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Baseline Demographic and Clinical Characteristics — build_demog_characteristics_table","title":"Baseline Demographic and Clinical Characteristics — build_demog_characteristics_table","text":"Baseline Demographic Clinical Characteristics","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_demog_characteristics_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Baseline Demographic and Clinical Characteristics — build_demog_characteristics_table","text":"","code":"build_demog_characteristics_table(   title = \"x.x: Study Subject Data\",   subtitle = c(\"x.x.x: Demographic Characteristics\",     \"Table x.x.x.x: Demographic Characteristics - Full Analysis Set\"),   footer = \"Source: ADSL DDMMYYYY hh:mm; Listing x.xx; SDTM package: DDMMYYYY\",   split_cols_by = \"ARM\",   summ_vars = c(\"AGE\", \"SEX\", \"COUNTRY\") )"},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_demog_characteristics_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Baseline Demographic and Clinical Characteristics — build_demog_characteristics_table","text":"title (character) Title demographic table. subtitle (character) Subtitle demographic table. footer (character) Footer demographic table. split_cols_by (character) Arm variable used split table columns. summ_vars (vector character) Variables df include table.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_demog_characteristics_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Baseline Demographic and Clinical Characteristics — build_demog_characteristics_table","text":"tabletree object.","code":""},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_demog_characteristics_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Baseline Demographic and Clinical Characteristics — build_demog_characteristics_table","text":"","code":"lyt <- build_demog_characteristics_table(   split_cols_by = \"ARM\",   summ_vars = c(\"AGE\", \"RACE\") )   ## Use the tabletree object to within build_table rtables::build_table(lyt, random.cdisc.data::cadsl) #> x.x: Study Subject Data #> x.x.x: Demographic Characteristics #> Table x.x.x.x: Demographic Characteristics - Full Analysis Set #>  #> ------------------------------------------------------------------------------------------------------- #>                                                A: Drug X    B: Placebo    C: Combination   All Patients #> Characteristic                                  (N=134)       (N=134)        (N=132)         (N=400)    #> ------------------------------------------------------------------------------------------------------- #> AGE                                                                                                     #>   n                                               134           134            132             400      #>   Mean, SD                                    33.8 (6.6)    35.4 (7.9)      35.4 (7.7)      34.9 (7.4)  #>   Standard Error                                  0.6           0.7            0.7             0.4      #>   Median                                         33.0          35.0            35.0            34.0     #>   Min-Max                                     21.0 - 50.0   21.0 - 62.0    20.0 - 69.0     20.0 - 69.0  #>   IQR                                         28.0 - 39.0   30.0 - 40.0    30.0 - 40.0     29.0 - 39.0  #> RACE                                                                                                    #>   n                                               134           134            132             400      #>   ASIAN                                       68 (50.7%)     67 (50%)       73 (55.3%)      208 (52%)   #>   BLACK OR AFRICAN AMERICAN                   31 (23.1%)    28 (20.9%)      32 (24.2%)      91 (22.8%)  #>   WHITE                                       27 (20.1%)    26 (19.4%)      21 (15.9%)      74 (18.5%)  #>   AMERICAN INDIAN OR ALASKA NATIVE              8 (6%)       11 (8.2%)       6 (4.5%)       25 (6.2%)   #>   MULTIPLE                                         0         1 (0.7%)           0            1 (0.2%)   #>   NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER        0         1 (0.7%)           0            1 (0.2%)   #>   OTHER                                            0             0              0               0       #>   UNKNOWN                                          0             0              0               0       #> ------------------------------------------------------------------------------------------------------- #>  #> Source: ADSL DDMMYYYY hh:mm; Listing x.xx; SDTM package: DDMMYYYY"},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_disp_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Disposition Summary Table — build_disp_table","title":"Disposition Summary Table — build_disp_table","text":"Disposition Summary Table","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_disp_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Disposition Summary Table — build_disp_table","text":"","code":"build_disp_table(   adsl,   trt_var,   eos_var = \"EOSSTT\",   eot_var = \"EOTSTT\",   dcs_reas = \"DCSREAS\",   dct_reas = \"DCTREAS\" )"},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_disp_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Disposition Summary Table — build_disp_table","text":"adsl (data.frame) adsl data set. trt_var (character) Arm variable used split table columns. eos_var (character) Name end study variable, default \"EOSSTT\". eot_var (character) Name end treatment variable, default \"EOTSTT\". dcs_reas (character) Name study discontinuation reason variable, default \"DCSREAS\". dct_reas (character) Name treatment discontinuation reason variable, default \"DCTREAS\".","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_disp_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Disposition Summary Table — build_disp_table","text":"rtable object Disposition Summary Table","code":""},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_disp_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Disposition Summary Table — build_disp_table","text":": Drug X B: Placebo C: Combination Patients  (N=134) (N=134) (N=132) (N=400) ITT Population 134 (100.00%) 134 (100.00%) 132 (100.00%) 400 (100.00%) Safety Population 134 (100.00%) 134 (100.00%) 132 (100.00%) 400 (100.00%) Discontinued Study 42 (31.3%) 40 (29.9%) 38 (28.8%) 120 (30.0%) ADVERSE EVENT 3 (2.2%) 6 (4.5%) 5 (3.8%) 14 (3.5%) DEATH 25 (18.7%) 23 (17.2%) 22 (16.7%) 70 (17.5%) LACK EFFICACY 2 (1.5%) 2 (1.5%) 3 (2.3%) 7 (1.8%) PHYSICIAN DECISION 2 (1.5%) 3 (2.2%) 2 (1.5%) 7 (1.8%) PROTOCOL VIOLATION 5 (3.7%) 3 (2.2%) 4 (3%) 12 (3%) WITHDRAWAL PARENT/GUARDIAN 4 (3%) 2 (1.5%) 1 (0.8%) 7 (1.8%) WITHDRAWAL SUBJECT 1 (0.7%) 1 (0.7%) 1 (0.8%) 3 (0.8%) Completed Treatment 68 (50.75%) 66 (49.25%) 73 (55.30%) 207 (51.75%) Ongoing Treatment 24 (17.91%) 28 (20.90%) 21 (15.91%) 73 (18.25%) Discontinued Treatment 42 (31.3%) 40 (29.9%) 38 (28.8%) 120 (30.0%)","code":"library(clinTables) library(rtables)  data(adsl)  tbl <- build_disp_table(   adsl = adsl,   trt_var = \"ARM\",   eos_var = \"EOSSTT\",   eot_var = \"EOTSTT\",   dcs_reas = \"DCSREAS\",   dct_reas = \"DCTREAS\" )  # \\dontrun{ tt_to_flextable(tbl) .cl-908f1464{table-layout:auto;}.cl-9087bc78{font-family:'Arial';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-9087bc79{font-family:'courier';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-908ae718{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-908ae719{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-908ae71a{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:0;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-908ae71b{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:10pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-908ae71c{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-908ae71d{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-908ae71e{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-908ae71f{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-908ae720{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-908ae721{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-908ae722{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-908b0a36{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-908b0a37{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-908b0a38{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-908b0a39{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-908b0a3a{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}A: Drug XB: PlaceboC: CombinationAll Patients(N=134)(N=134)(N=132)(N=400)ITT Population134 (100.00%)134 (100.00%)132 (100.00%)400 (100.00%)Safety Population134 (100.00%)134 (100.00%)132 (100.00%)400 (100.00%)Discontinued Study42 (31.3%)40 (29.9%)38 (28.8%)120 (30.0%)  ADVERSE EVENT3 (2.2%)6 (4.5%)5 (3.8%)14 (3.5%)  DEATH25 (18.7%)23 (17.2%)22 (16.7%)70 (17.5%)  LACK OF EFFICACY2 (1.5%)2 (1.5%)3 (2.3%)7 (1.8%)  PHYSICIAN DECISION2 (1.5%)3 (2.2%)2 (1.5%)7 (1.8%)  PROTOCOL VIOLATION5 (3.7%)3 (2.2%)4 (3%)12 (3%)  WITHDRAWAL BY PARENT/GUARDIAN4 (3%)2 (1.5%)1 (0.8%)7 (1.8%)  WITHDRAWAL BY SUBJECT1 (0.7%)1 (0.7%)1 (0.8%)3 (0.8%)Completed Treatment68 (50.75%)66 (49.25%)73 (55.30%)207 (51.75%)Ongoing Treatment24 (17.91%)28 (20.90%)21 (15.91%)73 (18.25%)Discontinued Treatment42 (31.3%)40 (29.9%)38 (28.8%)120 (30.0%)# }"},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_generic_bds_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Create generic BDS Summary table — build_generic_bds_table","text":"","code":"build_generic_bds_table(   bds_df,   filter_cond = NULL,   param,   trt_var,   visit = \"AVISIT\",   timepoint = NULL,   disp_vars )"},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_generic_bds_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Create generic BDS Summary table — build_generic_bds_table","text":"bds_df (data.frame) BDS dataset (typically ADVS, ADLB etc) filter_cond (character) Filtering condition required bds_df. param (character) BDS parameter value PARAM trt_var (character) Arm variable used split table columns. visit (character) Visit variable name eg. AVISIT timepoint (character) Timepoint variable name eg. ATPT disp_vars (vector characters) Variables summarize","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_generic_bds_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Create generic BDS Summary table — build_generic_bds_table","text":"List containing Generic BDS table layout filtered BDS data","code":""},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_generic_bds_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Create generic BDS Summary table — build_generic_bds_table","text":"Analysis Visit : Drug X B: Placebo C: Combination Summary Statistic Analysis Value Absolute Change Baseline Analysis Value Absolute Change Baseline Analysis Value Absolute Change Baseline  (N=134) (N=134) (N=134) (N=134) (N=132) (N=132) SCREENING       n 134 0 134 0 132 0 Mean (SD) 99.9 (18.0) NA 101.9 (21.1) NA 100.5 (19.1) NA Median 99.3 NA 100.2 NA 99.1 NA Min - Max 54.2 - 153.0 NA 48.2 - 148.0 NA 42.2 - 150.0 NA BASELINE       n 134 134 134 134 132 132 Mean (SD) 96.5 (19.9) 0.0 (0.0) 101.1 (19.9) 0.0 (0.0) 102.8 (19.5) 0.0 (0.0) Median 96.0 0.0 100.4 0.0 102.0 0.0 Min - Max 44.3 - 136.6 0.0 - 0.0 29.2 - 143.8 0.0 - 0.0 49.4 - 153.5 0.0 - 0.0 WEEK 1 DAY 8       n 134 134 134 134 132 132 Mean (SD) 100.6 (18.8) 4.1 (26.9) 99.2 (19.4) -1.9 (27.4) 97.1 (19.7) -5.6 (25.9) Median 100.2 1.5 99.4 -2.8 94.2 -5.6 Min - Max 57.6 - 147.5 -50.9 - 74.8 59.3 - 141.2 -64.5 - 70.9 51.0 - 142.5 -55.2 - 56.1 WEEK 2 DAY 15       n 134 134 134 134 132 132 Mean (SD) 102.1 (19.6) 5.6 (29.4) 99.3 (21.1) -1.8 (31.1) 100.0 (20.8) -2.8 (29.1) Median 103.6 7.8 100.6 -1.8 102.5 -5.7 Min - Max 54.7 - 150.8 -59.7 - 98.1 51.6 - 145.3 -71.0 - 92.4 37.1 - 138.9 -73.1 - 76.8 WEEK 3 DAY 22       n 134 134 134 134 132 132 Mean (SD) 101.8 (19.5) 5.3 (27.2) 97.7 (19.9) -3.4 (27.8) 99.9 (19.2) -2.9 (27.3) Median 100.4 6.5 98.8 -5.8 100.1 -1.5 Min - Max 47.7 - 162.2 -64.5 - 76.6 36.3 - 142.8 -70.2 - 84.7 53.8 - 146.4 -74.3 - 67.5 WEEK 4 DAY 29       n 134 134 134 134 132 132 Mean (SD) 100.2 (20.2) 3.7 (27.2) 99.1 (17.8) -2.0 (26.6) 99.3 (20.1) -3.5 (27.6) Median 98.2 3.0 98.0 -1.9 99.6 -0.5 Min - Max 48.5 - 153.4 -77.3 - 61.9 56.8 - 142.5 -83.0 - 89.9 46.9 - 146.1 -88.7 - 70.9 WEEK 5 DAY 36       n 134 134 134 134 132 132 Mean (SD) 101.4 (18.8) 4.9 (28.0) 95.9 (19.9) -5.2 (29.3) 97.7 (18.9) -5.0 (26.6) Median 98.6 3.9 94.3 -7.2 98.1 -5.6 Min - Max 62.7 - 155.5 -63.1 - 78.7 51.1 - 151.5 -78.1 - 72.9 51.5 - 157.3 -76.1 - 86.4","code":"library(clinTables) library(rtables) data(adsl) data(advs)  lyt <- build_generic_bds_table(advs,   param = \"Diastolic Blood Pressure\",   trt_var = \"ARM\", visit = \"AVISIT\",   disp_vars = c(\"AVAL\", \"CHG\") ) # \\dontrun{ tt_to_flextable(build_table(lyt = lyt$lyt, df = lyt$df_out, alt_counts_df = adsl)) .cl-918484b2{table-layout:auto;}.cl-917a80ca{font-family:'Arial';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-917a80cb{font-family:'courier';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-917dcec4{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-917dcec5{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-917dcec6{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:10pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-917dcec7{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:20pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-917dcec8{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-917dcec9{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-917dceca{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-917dcecb{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-917dcecc{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-917dcecd{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-917dcece{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-917df5ca{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-917df5cb{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-917df5cc{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-917df5cd{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-917df5ce{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-917df5cf{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-917df5d0{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-917df5d1{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-917df5d2{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-917df5d3{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-917df5d4{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}Analysis VisitA: Drug XB: PlaceboC: Combination  Summary StatisticAnalysis ValueAbsolute Change from BaselineAnalysis ValueAbsolute Change from BaselineAnalysis ValueAbsolute Change from Baseline(N=134)(N=134)(N=134)(N=134)(N=132)(N=132)  SCREENING    n134013401320    Mean (SD)99.9 (18.0)NA101.9 (21.1)NA100.5 (19.1)NA    Median99.3NA100.2NA99.1NA    Min - Max54.2 - 153.0NA48.2 - 148.0NA42.2 - 150.0NA  BASELINE    n134134134134132132    Mean (SD)96.5 (19.9)0.0 (0.0)101.1 (19.9)0.0 (0.0)102.8 (19.5)0.0 (0.0)    Median96.00.0100.40.0102.00.0    Min - Max44.3 - 136.60.0 - 0.029.2 - 143.80.0 - 0.049.4 - 153.50.0 - 0.0  WEEK 1 DAY 8    n134134134134132132    Mean (SD)100.6 (18.8)4.1 (26.9)99.2 (19.4)-1.9 (27.4)97.1 (19.7)-5.6 (25.9)    Median100.21.599.4-2.894.2-5.6    Min - Max57.6 - 147.5-50.9 - 74.859.3 - 141.2-64.5 - 70.951.0 - 142.5-55.2 - 56.1  WEEK 2 DAY 15    n134134134134132132    Mean (SD)102.1 (19.6)5.6 (29.4)99.3 (21.1)-1.8 (31.1)100.0 (20.8)-2.8 (29.1)    Median103.67.8100.6-1.8102.5-5.7    Min - Max54.7 - 150.8-59.7 - 98.151.6 - 145.3-71.0 - 92.437.1 - 138.9-73.1 - 76.8  WEEK 3 DAY 22    n134134134134132132    Mean (SD)101.8 (19.5)5.3 (27.2)97.7 (19.9)-3.4 (27.8)99.9 (19.2)-2.9 (27.3)    Median100.46.598.8-5.8100.1-1.5    Min - Max47.7 - 162.2-64.5 - 76.636.3 - 142.8-70.2 - 84.753.8 - 146.4-74.3 - 67.5  WEEK 4 DAY 29    n134134134134132132    Mean (SD)100.2 (20.2)3.7 (27.2)99.1 (17.8)-2.0 (26.6)99.3 (20.1)-3.5 (27.6)    Median98.23.098.0-1.999.6-0.5    Min - Max48.5 - 153.4-77.3 - 61.956.8 - 142.5-83.0 - 89.946.9 - 146.1-88.7 - 70.9  WEEK 5 DAY 36    n134134134134132132    Mean (SD)101.4 (18.8)4.9 (28.0)95.9 (19.9)-5.2 (29.3)97.7 (18.9)-5.0 (26.6)    Median98.63.994.3-7.298.1-5.6    Min - Max62.7 - 155.5-63.1 - 78.751.1 - 151.5-78.1 - 72.951.5 - 157.3-76.1 - 86.4# }"},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_generic_occurrence_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Create Generic Occurrence Summary Table — build_generic_occurrence_table","text":"","code":"build_generic_occurrence_table(   occ_df,   filter_cond = NULL,   trt_var,   dataset,   class_var,   term_var )"},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_generic_occurrence_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Create Generic Occurrence Summary Table — build_generic_occurrence_table","text":"occ_df (data.frame) Occurrence dataset (typically ADAE, ADMH etc) filter_cond (character) Filtering condition required occ_df. trt_var (character) Arm variable used split table columns. dataset (character) Name dataset eg. \"cadae\". class_var (character) Body system organ class variable. term_var (character) Preferred term variable occ_df include table.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_generic_occurrence_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Create Generic Occurrence Summary Table — build_generic_occurrence_table","text":"List containing table layout object Generic Occurrence Table filtered Occurrencedata","code":""},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_generic_occurrence_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Create Generic Occurrence Summary Table — build_generic_occurrence_table","text":"Primary System Organ Class : Drug X B: Placebo C: Combination Patients Dictionary-Derived Term (N=134) (N=134) (N=132) (N=400) Total number patients least one event 122 (91.0%) 123 (91.8%) 120 (90.9%) 365 (91.2%) Total number events 609 622 703 1934 cl 78 (58.2%) 75 (56.0%) 89 (67.4%) 242 (60.5%) dcd .1.1.1.1 50 (37.3%) 45 (33.6%) 63 (47.7%) 158 (39.5%) dcd .1.1.1.2 48 (35.8%) 48 (35.8%) 50 (37.9%) 146 (36.5%) cl B 96 (71.6%) 89 (66.4%) 97 (73.5%) 282 (70.5%) dcd B.1.1.1.1 47 (35.1%) 49 (36.6%) 43 (32.6%) 139 (34.8%) dcd B.2.1.2.1 49 (36.6%) 44 (32.8%) 52 (39.4%) 145 (36.2%) dcd B.2.2.3.1 48 (35.8%) 54 (40.3%) 51 (38.6%) 153 (38.2%) cl C 67 (50.0%) 75 (56.0%) 79 (59.8%) 221 (55.2%) dcd C.1.1.1.3 43 (32.1%) 46 (34.3%) 43 (32.6%) 132 (33.0%) dcd C.2.1.2.1 35 (26.1%) 48 (35.8%) 55 (41.7%) 138 (34.5%) cl D 96 (71.6%) 90 (67.2%) 98 (74.2%) 284 (71.0%) dcd D.1.1.1.1 50 (37.3%) 42 (31.3%) 51 (38.6%) 143 (35.8%) dcd D.1.1.4.2 48 (35.8%) 42 (31.3%) 50 (37.9%) 140 (35.0%) dcd D.2.1.5.3 47 (35.1%) 58 (43.3%) 57 (43.2%) 162 (40.5%)","code":"library(clinTables) library(rtables) library(tern) library(dplyr) data(adsl) data(adae) adae <- filter(adae, SAFFL == \"Y\")  lyt <- build_generic_occurrence_table(   occ_df = adae,   filter_cond = NULL,   trt_var = \"ARM\",   dataset = \"adae\",   class_var = \"AESOC\",   term_var = \"AEDECOD\" ) tbl <- build_table(lyt = lyt$lyt, df = lyt$df_out, alt_counts_df = adsl)  # \\dontrun{ tt_to_flextable(tbl) .cl-9235376c{table-layout:auto;}.cl-922e31ba{font-family:'Arial';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-922e31bb{font-family:'courier';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-923113d0{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-923113d1{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-923113d2{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:0;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-923113d3{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:20pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-923113d4{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:30pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-923113d5{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-923113d6{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-923113d7{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-923113d8{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-923113d9{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-923113da{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-92313914{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-92313915{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-92313916{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-92313917{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-92313918{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-92313919{background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9231391a{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9231391b{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9231391c{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9231391d{background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}Primary System Organ ClassA: Drug XB: PlaceboC: CombinationAll Patients  Dictionary-Derived Term(N=134)(N=134)(N=132)(N=400)Total number of patients with at least one event122 (91.0%)123 (91.8%)120 (90.9%)365 (91.2%)Total number of events6096227031934    cl A78 (58.2%)75 (56.0%)89 (67.4%)242 (60.5%)      dcd A.1.1.1.150 (37.3%)45 (33.6%)63 (47.7%)158 (39.5%)      dcd A.1.1.1.248 (35.8%)48 (35.8%)50 (37.9%)146 (36.5%)    cl B96 (71.6%)89 (66.4%)97 (73.5%)282 (70.5%)      dcd B.1.1.1.147 (35.1%)49 (36.6%)43 (32.6%)139 (34.8%)      dcd B.2.1.2.149 (36.6%)44 (32.8%)52 (39.4%)145 (36.2%)      dcd B.2.2.3.148 (35.8%)54 (40.3%)51 (38.6%)153 (38.2%)    cl C67 (50.0%)75 (56.0%)79 (59.8%)221 (55.2%)      dcd C.1.1.1.343 (32.1%)46 (34.3%)43 (32.6%)132 (33.0%)      dcd C.2.1.2.135 (26.1%)48 (35.8%)55 (41.7%)138 (34.5%)    cl D96 (71.6%)90 (67.2%)98 (74.2%)284 (71.0%)      dcd D.1.1.1.150 (37.3%)42 (31.3%)51 (38.6%)143 (35.8%)      dcd D.1.1.4.248 (35.8%)42 (31.3%)50 (37.9%)140 (35.0%)      dcd D.2.1.5.347 (35.1%)58 (43.3%)57 (43.2%)162 (40.5%)# }"},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_shift_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Create Shift Table — build_shift_table","title":"Create Shift Table — build_shift_table","text":"Shift Tables show progression change baseline, progression often along time; number subjects displayed different range (e.g. low, normal, high) baseline selected time points intervals.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_shift_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Create Shift Table — build_shift_table","text":"","code":"build_shift_table(   adsl,   bds_df,   filter_cond = NULL,   trt_var,   trt_label = NULL,   group_var = NULL,   group_label = NULL,   default_view = TRUE )"},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_shift_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Create Shift Table — build_shift_table","text":"adsl (data.frame)adsl data frame. bds_df (data.frame)bds data frame eg. adlb, advs. filter_cond (character) Filtering condition required bds_df. trt_var (character)  Name treatment variable adsl treatment count, eg. ARM. Must vector length 1. trt_label (named vector character) Label trt_var. Must named vector length 1. group_var (vector characters) Names variables grouping addition parameter. Default NULL. group_label (named vector characters) Label group_var. default_view (logical) TRUE (default), values trt_var shown rows, else columns.","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_shift_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Create Shift Table — build_shift_table","text":"Flextable object Shift Table","code":""},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/build_shift_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Create Shift Table — build_shift_table","text":"Parameter Baseline Reference Range Indicator  : Drug X (N=134)  B: Placebo (N=134)  C: Combination (N=132)  HIGH  LOW  NORMAL  HIGH  LOW  NORMAL  HIGH  LOW  NORMAL  n %  n %  n %  n %  n %  n %  n %  n %  n % Alanine Aminotransferase Measurement HIGH  0 0.0  0 0.0  0 0.0  0 0.0  0 0.0  0 0.0  0 0.0  0 0.0  0 0.0 LOW  0 0.0  0 0.0  21 15.7  0 0.0  0 0.0  17 12.7  0 0.0  0 0.0  9 6.8 NORMAL  0 0.0  0 0.0  113 84.3  0 0.0  0 0.0  117 87.3  0 0.0  0 0.0  123 93.2 Total  0 0.0  0 0.0  134 100.0  0 0.0  0 0.0  134 100.0  0 0.0  0 0.0  132 100.0 C-Reactive Protein Measurement HIGH  20 14.9  0 0.0  0 0.0  22 16.4  0 0.0  0 0.0  17 12.9  0 0.0  0 0.0 LOW  13 9.7  0 0.0  2 1.5  10 7.5  0 0.0  11 8.2  14 10.6  0 0.0  6 4.5 NORMAL  67 50.0  0 0.0  32 23.9  51 38.1  0 0.0  40 29.9  59 44.7  0 0.0  36 27.3 Total  100 74.6  0 0.0  34 25.4  83 61.9  0 0.0  51 38.1  90 68.2  0 0.0  42 31.8 Immunoglobulin Measurement HIGH  15 11.2  0 0.0  0 0.0  18 13.4  0 0.0  0 0.0  19 14.4  0 0.0  0 0.0 LOW  0 0.0  0 0.0  0 0.0  0 0.0  0 0.0  0 0.0  0 0.0  0 0.0  0 0.0 NORMAL  69 51.5  0 0.0  50 37.3  70 52.2  0 0.0  46 34.3  71 53.8  0 0.0  42 31.8 Total  84 62.7  0 0.0  50 37.3  88 65.7  0 0.0  46 34.3  90 68.2  0 0.0  42 31.8","code":"library(clinTables) data(adsl) data(adlb)  # \\dontrun{ build_shift_table(   adsl = adsl,   bds_df = adlb,   filter_cond = NULL,   trt_var = \"ARM\",   trt_label = c(ARM = \"Description of Planned Arm\"),   group_var = NULL, ,   default_view = FALSE ) #> Joining with `by = join_by(USUBJID, ARM)` .cl-932876ca{}.cl-931d51fa{font-family:'Arial';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-9320f2ec{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-9320f2ed{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:0;padding-top:0;padding-left:0;padding-right:0;line-height: 1;background-color:transparent;}.cl-9320f2ee{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-9320f2ef{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:0;padding-top:0;padding-left:0;padding-right:0;line-height: 1;background-color:transparent;}.cl-9320f2f0{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-9320f2f1{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:0;padding-top:0;padding-left:0;padding-right:0;line-height: 1;background-color:transparent;}.cl-9320f2f2{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-932119fc{width:2.99in;background-color:transparent;vertical-align: bottom;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932119fd{width:2.718in;background-color:transparent;vertical-align: bottom;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932119fe{width:0.079in;background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932119ff{width:0.519in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93211a00{width:0.561in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93211a01{width:0.349in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93211a02{width:0.476in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93211a03{width:0.646in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93211a04{width:0.434in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93211a05{width:2.99in;background-color:transparent;vertical-align: bottom;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93211a06{width:2.718in;background-color:transparent;vertical-align: bottom;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932140e4{width:0.079in;background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932140e5{width:0.519in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932140e6{width:0.561in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932140e7{width:0.349in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932140e8{width:0.476in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932140e9{width:0.646in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932140ea{width:0.434in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932140eb{width:2.99in;background-color:transparent;vertical-align: bottom;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932140ec{width:2.718in;background-color:transparent;vertical-align: bottom;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932140ed{width:0.079in;background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932140ee{width:0.519in;background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932167ea{width:0.561in;background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932167eb{width:0.349in;background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932167ec{width:0.476in;background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932167ed{width:0.646in;background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932167ee{width:0.434in;background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932167ef{width:2.99in;background-color:transparent;vertical-align: top;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932167f0{width:2.718in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932167f1{width:0.079in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932167f2{width:0.519in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932167f3{width:0.561in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-932167f4{width:0.349in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93218f04{width:0.476in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93218f05{width:0.646in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93218f06{width:0.434in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93218f07{width:2.99in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93218f08{width:2.718in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93218f09{width:0.079in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93218f0a{width:0.519in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93218f0b{width:0.561in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93218f0c{width:0.349in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93218f0d{width:0.476in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93218f0e{width:0.646in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93219472{width:0.434in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93219473{width:2.99in;background-color:transparent;vertical-align: top;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93219474{width:2.718in;background-color:transparent;vertical-align: top;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93219475{width:0.079in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93219476{width:0.519in;background-color:transparent;vertical-align: top;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93219477{width:0.561in;background-color:transparent;vertical-align: top;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93219478{width:0.349in;background-color:transparent;vertical-align: top;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93219479{width:0.476in;background-color:transparent;vertical-align: top;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321947a{width:0.646in;background-color:transparent;vertical-align: top;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321947b{width:0.434in;background-color:transparent;vertical-align: top;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321947c{width:2.99in;background-color:transparent;vertical-align: top;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321958a{width:2.718in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321958b{width:0.519in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321958c{width:0.561in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321958d{width:0.349in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321958e{width:0.476in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321958f{width:0.646in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93219590{width:0.434in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93219591{width:2.718in;background-color:transparent;vertical-align: top;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93219592{width:0.519in;background-color:transparent;vertical-align: top;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93219593{width:0.561in;background-color:transparent;vertical-align: top;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-93219594{width:0.349in;background-color:transparent;vertical-align: top;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321a926{width:0.476in;background-color:transparent;vertical-align: top;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321a927{width:0.646in;background-color:transparent;vertical-align: top;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321a928{width:0.434in;background-color:transparent;vertical-align: top;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321a929{width:2.99in;background-color:transparent;vertical-align: top;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321a92a{width:2.718in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321a92b{width:0.079in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321a92c{width:0.519in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321a92d{width:0.561in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321a92e{width:0.349in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321a92f{width:0.476in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321a930{width:0.646in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321db8a{width:0.434in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321db8b{width:2.99in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321db8c{width:2.718in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321db8d{width:0.519in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321db8e{width:0.561in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321db8f{width:0.349in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321db90{width:0.476in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321db91{width:0.646in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321db92{width:0.434in;background-color:transparent;vertical-align: top;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321db93{width:2.99in;background-color:transparent;vertical-align: top;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9321db94{width:2.718in;background-color:transparent;vertical-align: top;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9322029a{width:0.519in;background-color:transparent;vertical-align: top;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9322029b{width:0.561in;background-color:transparent;vertical-align: top;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9322029c{width:0.349in;background-color:transparent;vertical-align: top;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9322029d{width:0.476in;background-color:transparent;vertical-align: top;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9322029e{width:0.646in;background-color:transparent;vertical-align: top;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-9322029f{width:0.434in;background-color:transparent;vertical-align: top;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}ParameterBaseline Reference Range IndicatorA: Drug X (N=134)B: Placebo (N=134)C: Combination (N=132)HIGHLOWNORMALHIGHLOWNORMALHIGHLOWNORMALn%n%n%n%n%n%n%n%n%Alanine Aminotransferase MeasurementHIGH00.000.000.000.000.000.000.000.000.0LOW00.000.02115.700.000.01712.700.000.096.8NORMAL00.000.011384.300.000.011787.300.000.012393.2Total00.000.0134100.000.000.0134100.000.000.0132100.0C-Reactive Protein MeasurementHIGH2014.900.000.02216.400.000.01712.900.000.0LOW139.700.021.5107.500.0118.21410.600.064.5NORMAL6750.000.03223.95138.100.04029.95944.700.03627.3Total10074.600.03425.48361.900.05138.19068.200.04231.8Immunoglobulin A MeasurementHIGH1511.200.000.01813.400.000.01914.400.000.0LOW00.000.000.000.000.000.000.000.000.0NORMAL6951.500.05037.37052.200.04634.37153.800.04231.8Total8462.700.05037.38865.700.04634.39068.200.04231.8# }"},{"path":"https://ahasoplakus.github.io/clinTables/reference/clinTables-package.html","id":null,"dir":"Reference","previous_headings":"","what":"clinTables: Clinical Trial Tables in R — clinTables-package","title":"clinTables: Clinical Trial Tables in R — clinTables-package","text":"Shiny Application visualizing standard tables used Clinical Trials.","code":""},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/reference/clinTables-package.html","id":"author","dir":"Reference","previous_headings":"","what":"Author","title":"clinTables: Clinical Trial Tables in R — clinTables-package","text":"Maintainer: Sukalpo Saha sukalposaha@gmail.com","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/filters_to_cond.html","id":null,"dir":"Reference","previous_headings":"","what":"Create filtering condition based on filters — filters_to_cond","title":"Create filtering condition based on filters — filters_to_cond","text":"Create filtering condition based filters","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/filters_to_cond.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Create filtering condition based on filters — filters_to_cond","text":"","code":"filters_to_cond(filter_list)"},{"path":"https://ahasoplakus.github.io/clinTables/reference/filters_to_cond.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Create filtering condition based on filters — filters_to_cond","text":"filter_list (list) Named list filter values","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/filters_to_cond.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Create filtering condition based on filters — filters_to_cond","text":"Filtering condition","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/filters_to_cond.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Create filtering condition based on filters — filters_to_cond","text":"","code":"filter_list <- list(SEX = c(\"F\", \"M\")) filters_to_cond(filter_list) #> SEX %in% c('F','M')"},{"path":"https://ahasoplakus.github.io/clinTables/reference/run_app.html","id":null,"dir":"Reference","previous_headings":"","what":"Run the Shiny Application — run_app","title":"Run the Shiny Application — run_app","text":"Run Shiny Application","code":""},{"path":"https://ahasoplakus.github.io/clinTables/reference/run_app.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Run the Shiny Application — run_app","text":"","code":"run_app(   onStart = NULL,   options = list(shiny.maxRequestSize = 10000 * 1024^2),   enableBookmarking = NULL,   uiPattern = \"/\",   ... )"},{"path":"https://ahasoplakus.github.io/clinTables/reference/run_app.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Run the Shiny Application — run_app","text":"onStart function called app actually run. needed shinyAppObj, since shinyAppDir case, global.R file can used purpose. options Named options passed runApp call (can following: \"port\", \"launch.browser\", \"host\", \"quiet\", \"display.mode\" \"test.mode\"). can also specify width height parameters provide hint embedding environment ideal height/width app. enableBookmarking Can one \"url\", \"server\", \"disable\". default value, NULL, respect setting previous calls  enableBookmarking(). See enableBookmarking() information bookmarking app. uiPattern regular expression applied GET request determine whether ui used handle request. Note entire request path must match regular expression order match considered successful. ... arguments pass golem_opts. See ?golem::get_golem_options details.","code":""},{"path":[]},{"path":"https://ahasoplakus.github.io/clinTables/news/index.html","id":"clintables-0009000","dir":"Changelog","previous_headings":"","what":"clinTables 0.0.0.9000","title":"clinTables 0.0.0.9000","text":"Added NEWS.md file track changes package.","code":""}]
